These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7615652

  • 21. c-Myc induces the expression and activity of ornithine decarboxylase.
    Wagner AJ, Meyers C, Laimins LA, Hay N.
    Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML, Chou YW, Chau YP, Huang TS.
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [Abstract] [Full Text] [Related]

  • 24. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
    Hayes CS, DeFeo K, Lan L, Paul B, Sell C, Gilmour SK.
    Oncogene; 2006 Mar 09; 25(10):1543-53. PubMed ID: 16278677
    [Abstract] [Full Text] [Related]

  • 25. Ornithine decarboxylase regulates the activity and localization of rhoA via polyamination.
    Mäkitie LT, Kanerva K, Andersson LC.
    Exp Cell Res; 2009 Apr 01; 315(6):1008-14. PubMed ID: 19331812
    [Abstract] [Full Text] [Related]

  • 26. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
    Terleth C, van Laar T, Schouten R, van Steeg H, Hodemaekers H, Wormhoudt T, Cornelissen-Steijger PD, Abrahams PJ, van der Eb AJ.
    Cancer Res; 1997 Oct 01; 57(19):4384-92. PubMed ID: 9331102
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation.
    Shantz LM, Pegg AE.
    Cancer Res; 1994 May 01; 54(9):2313-6. PubMed ID: 8162572
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. DNA methylation affecting the transforming activity of the human Ha-ras oncogene.
    Borrello MG, Pierotti MA, Bongarzone I, Donghi R, Mondellini P, Della Porta G.
    Cancer Res; 1987 Jan 01; 47(1):75-9. PubMed ID: 2431768
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
    Lan L, Trempus C, Gilmour SK.
    Cancer Res; 2000 Oct 15; 60(20):5696-703. PubMed ID: 11059762
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H, Geng Y, Pramanik R, Choubey D.
    J Cell Biochem; 2003 Jan 01; 88(1):191-204. PubMed ID: 12461788
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Certain changes in ornithine decarboxylase gene methylation accompany gene amplification.
    Wahlfors J.
    Biochem J; 1991 Oct 15; 279 ( Pt 2)(Pt 2):435-40. PubMed ID: 1719956
    [Abstract] [Full Text] [Related]

  • 39. DNA methylation of the Ha-ras-1 oncogene in neoplastic cells.
    Barbieri R, Mischiati C, Piva R, Nastruzzi C, Giacomini P, Natali PG, Gambari R.
    Anticancer Res; 1989 Oct 15; 9(6):1787-91. PubMed ID: 2697188
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.